C
Power Law company profile
Clinuvel Pharmaceuticals
Biotech & Life Sciences · Melbourne, Australia · Founded 2001 · IPO 2001 Unicorn
Valuation
$149M
Market cap · May/2026
Revenue
$61M
Latest reported FY
EBITDA
$27M
Latest reported FY
Global footprint
Where Clinuvel Pharmaceuticals has talent and traffic
Workforce by country
10
countries with
team presence
team presence
🇬🇧 United Kingdom40.5%
🇦🇺 Australia24.9%
🇺🇸 United States13.7%
🇸🇬 Singapore10.3%
🇨🇭 Switzerland4.6%
Market sentiment
What the market is saying about Clinuvel Pharmaceuticals
An AI-synthesized read of the highest-engagement posts about Clinuvel Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Clinuvel Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.